The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The global Pharmaceutical Contract Manufacturing & Contract market was valued at US$ 87830 million in 2023 and is anticipated to reach US$ 136820 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Manufacturing & Contract, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Manufacturing & Contract.
Report Scope
The Pharmaceutical Contract Manufacturing & Contract market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Contract Manufacturing & Contract market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Manufacturing & Contract companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List)
- Catalent
- Pharmaceutical Product Development LLC
- AbbVie
- Baxter BioPharma Solutions
- Patheon
- Grifols International
- Dalton Pharma Services
- Boehringer Ingelheim Biopharmaceuticals GmBh
- Lonza AG.
- Grifols S.A
- Jubilant Life Sciences Limited
- QuintilesIMS
- Vetter Pharma
- Ligand Pharmaceuticals, Inc.
- Bausch Health
- Recipharm AB
- Famar Health Care Services
- West Pharmaceutical Services, Inc.
Segment by Type
- Manufacturing
- Research
Segment by Application
- Small Medium Enterprise
- Large Enterprise
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Contract Manufacturing & Contract companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Manufacturing & Contract Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Manufacturing
1.2.3 Research
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Manufacturing & Contract Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Small Medium Enterprise
1.3.3 Large Enterprise
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Manufacturing & Contract Market Perspective (2019-2030)
2.2 Pharmaceutical Contract Manufacturing & Contract Growth Trends by Region
2.2.1 Global Pharmaceutical Contract Manufacturing & Contract Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Contract Manufacturing & Contract Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Contract Manufacturing & Contract Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Contract Manufacturing & Contract Market Dynamics
2.3.1 Pharmaceutical Contract Manufacturing & Contract Industry Trends
2.3.2 Pharmaceutical Contract Manufacturing & Contract Market Drivers
2.3.3 Pharmaceutical Contract Manufacturing & Contract Market Challenges
2.3.4 Pharmaceutical Contract Manufacturing & Contract Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Manufacturing & Contract Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Manufacturing & Contract Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Contract Manufacturing & Contract Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Contract Manufacturing & Contract Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Contract Manufacturing & Contract Revenue
3.4 Global Pharmaceutical Contract Manufacturing & Contract Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Manufacturing & Contract Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Manufacturing & Contract Revenue in 2023
3.5 Pharmaceutical Contract Manufacturing & Contract Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Contract Manufacturing & Contract Product Solution and Service
3.7 Date of Enter into Pharmaceutical Contract Manufacturing & Contract Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Contract Manufacturing & Contract Breakdown Data by Type
4.1 Global Pharmaceutical Contract Manufacturing & Contract Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Contract Manufacturing & Contract Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Contract Manufacturing & Contract Breakdown Data by Application
5.1 Global Pharmaceutical Contract Manufacturing & Contract Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Contract Manufacturing & Contract Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Contract Manufacturing & Contract Market Size (2019-2030)
6.2 North America Pharmaceutical Contract Manufacturing & Contract Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Contract Manufacturing & Contract Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Contract Manufacturing & Contract Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Manufacturing & Contract Market Size (2019-2030)
7.2 Europe Pharmaceutical Contract Manufacturing & Contract Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Contract Manufacturing & Contract Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Contract Manufacturing & Contract Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Manufacturing & Contract Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Contract Manufacturing & Contract Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Contract Manufacturing & Contract Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Contract Manufacturing & Contract Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Contract Manufacturing & Contract Market Size (2019-2030)
9.2 Latin America Pharmaceutical Contract Manufacturing & Contract Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Contract Manufacturing & Contract Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Contract Manufacturing & Contract Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Manufacturing & Contract Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Contract Manufacturing & Contract Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Contract Manufacturing & Contract Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Contract Manufacturing & Contract Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Pharmaceutical Contract Manufacturing & Contract Introduction
11.1.4 Catalent Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 Pharmaceutical Product Development LLC
11.2.1 Pharmaceutical Product Development LLC Company Detail
11.2.2 Pharmaceutical Product Development LLC Business Overview
11.2.3 Pharmaceutical Product Development LLC Pharmaceutical Contract Manufacturing & Contract Introduction
11.2.4 Pharmaceutical Product Development LLC Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.2.5 Pharmaceutical Product Development LLC Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Pharmaceutical Contract Manufacturing & Contract Introduction
11.3.4 AbbVie Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.3.5 AbbVie Recent Development
11.4 Baxter BioPharma Solutions
11.4.1 Baxter BioPharma Solutions Company Detail
11.4.2 Baxter BioPharma Solutions Business Overview
11.4.3 Baxter BioPharma Solutions Pharmaceutical Contract Manufacturing & Contract Introduction
11.4.4 Baxter BioPharma Solutions Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.4.5 Baxter BioPharma Solutions Recent Development
11.5 Patheon
11.5.1 Patheon Company Detail
11.5.2 Patheon Business Overview
11.5.3 Patheon Pharmaceutical Contract Manufacturing & Contract Introduction
11.5.4 Patheon Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.5.5 Patheon Recent Development
11.6 Grifols International
11.6.1 Grifols International Company Detail
11.6.2 Grifols International Business Overview
11.6.3 Grifols International Pharmaceutical Contract Manufacturing & Contract Introduction
11.6.4 Grifols International Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.6.5 Grifols International Recent Development
11.7 Dalton Pharma Services
11.7.1 Dalton Pharma Services Company Detail
11.7.2 Dalton Pharma Services Business Overview
11.7.3 Dalton Pharma Services Pharmaceutical Contract Manufacturing & Contract Introduction
11.7.4 Dalton Pharma Services Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.7.5 Dalton Pharma Services Recent Development
11.8 Boehringer Ingelheim Biopharmaceuticals GmBh
11.8.1 Boehringer Ingelheim Biopharmaceuticals GmBh Company Detail
11.8.2 Boehringer Ingelheim Biopharmaceuticals GmBh Business Overview
11.8.3 Boehringer Ingelheim Biopharmaceuticals GmBh Pharmaceutical Contract Manufacturing & Contract Introduction
11.8.4 Boehringer Ingelheim Biopharmaceuticals GmBh Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.8.5 Boehringer Ingelheim Biopharmaceuticals GmBh Recent Development
11.9 Lonza AG.
11.9.1 Lonza AG. Company Detail
11.9.2 Lonza AG. Business Overview
11.9.3 Lonza AG. Pharmaceutical Contract Manufacturing & Contract Introduction
11.9.4 Lonza AG. Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.9.5 Lonza AG. Recent Development
11.10 Grifols S.A
11.10.1 Grifols S.A Company Detail
11.10.2 Grifols S.A Business Overview
11.10.3 Grifols S.A Pharmaceutical Contract Manufacturing & Contract Introduction
11.10.4 Grifols S.A Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.10.5 Grifols S.A Recent Development
11.11 Jubilant Life Sciences Limited
11.11.1 Jubilant Life Sciences Limited Company Detail
11.11.2 Jubilant Life Sciences Limited Business Overview
11.11.3 Jubilant Life Sciences Limited Pharmaceutical Contract Manufacturing & Contract Introduction
11.11.4 Jubilant Life Sciences Limited Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.11.5 Jubilant Life Sciences Limited Recent Development
11.12 QuintilesIMS
11.12.1 QuintilesIMS Company Detail
11.12.2 QuintilesIMS Business Overview
11.12.3 QuintilesIMS Pharmaceutical Contract Manufacturing & Contract Introduction
11.12.4 QuintilesIMS Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.12.5 QuintilesIMS Recent Development
11.13 Vetter Pharma
11.13.1 Vetter Pharma Company Detail
11.13.2 Vetter Pharma Business Overview
11.13.3 Vetter Pharma Pharmaceutical Contract Manufacturing & Contract Introduction
11.13.4 Vetter Pharma Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.13.5 Vetter Pharma Recent Development
11.14 Ligand Pharmaceuticals, Inc.
11.14.1 Ligand Pharmaceuticals, Inc. Company Detail
11.14.2 Ligand Pharmaceuticals, Inc. Business Overview
11.14.3 Ligand Pharmaceuticals, Inc. Pharmaceutical Contract Manufacturing & Contract Introduction
11.14.4 Ligand Pharmaceuticals, Inc. Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.14.5 Ligand Pharmaceuticals, Inc. Recent Development
11.15 Bausch Health
11.15.1 Bausch Health Company Detail
11.15.2 Bausch Health Business Overview
11.15.3 Bausch Health Pharmaceutical Contract Manufacturing & Contract Introduction
11.15.4 Bausch Health Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.15.5 Bausch Health Recent Development
11.16 Recipharm AB
11.16.1 Recipharm AB Company Detail
11.16.2 Recipharm AB Business Overview
11.16.3 Recipharm AB Pharmaceutical Contract Manufacturing & Contract Introduction
11.16.4 Recipharm AB Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.16.5 Recipharm AB Recent Development
11.17 Famar Health Care Services
11.17.1 Famar Health Care Services Company Detail
11.17.2 Famar Health Care Services Business Overview
11.17.3 Famar Health Care Services Pharmaceutical Contract Manufacturing & Contract Introduction
11.17.4 Famar Health Care Services Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.17.5 Famar Health Care Services Recent Development
11.18 West Pharmaceutical Services, Inc.
11.18.1 West Pharmaceutical Services, Inc. Company Detail
11.18.2 West Pharmaceutical Services, Inc. Business Overview
11.18.3 West Pharmaceutical Services, Inc. Pharmaceutical Contract Manufacturing & Contract Introduction
11.18.4 West Pharmaceutical Services, Inc. Revenue in Pharmaceutical Contract Manufacturing & Contract Business (2019-2024)
11.18.5 West Pharmaceutical Services, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
